CEAT shares: Nuvama cuts to Hold, target Rs 3,900

Nuvama changes stance on CEAT

Nuvama Institutional Equities downgraded CEAT Ltd to ‘Hold’ from ‘Buy’, citing limited upside potential. The brokerage’s view comes despite what it described as a strong operational performance in the March quarter. The downgrade is a valuation and upside call rather than a direct critique of near-term operations. Nuvama’s revision adds to a busy research backdrop for CEAT, where price targets across brokerages span a wide range. For investors, the key question is how much of the operational momentum is already reflected in the share price.

Target price and valuation framework

Nuvama set a target price of Rs 3,900 for CEAT. It said it values the stock at 16 times FY28E earnings per share (EPS). Alongside the target, the brokerage flagged where the market is pricing CEAT on forward multiples. According to Nuvama, CEAT is currently trading at FY26E, FY27E and FY28E price-to-earnings (P/E) multiples of 19x, 20x and 15x, respectively. The combination of these inputs underpins the brokerage’s “limited upside” assessment.

What the downgrade implies

Moving to ‘Hold’ from ‘Buy’ typically signals that the brokerage expects returns closer to market averages from current levels, rather than material outperformance. In this case, Nuvama’s note suggests operational delivery in the March quarter has not been enough to offset valuation comfort. The brokerage’s target price of Rs 3,900 sits above some recent trading levels mentioned in market snapshots, but the change in rating indicates the risk-reward balance has tightened. For existing shareholders, the stance implies Nuvama sees fewer catalysts that can lift valuation meaningfully beyond its target band.

Where the stock traded on April 29, 2026

BSE market depth data dated 29 Apr 2026 showed CEAT around Rs 3,621.50. The snapshot indicated the stock was up Rs 104.25, or 2.96%, at the time of the update (as on 29 Apr, 2026 | 04:01). The day range captured in the same display was Rs 3,602.00 to Rs 3,946.70. Market depth also showed visible sell offers near Rs 3,648.90, Rs 3,650.00, Rs 3,663.00, Rs 3,665.00 and Rs 3,670.00, reflecting supply at higher levels in that view.

Analyst recommendations remain mixed

The broader analyst picture in the provided data set points to varied calls. A listed “Analysts’ Consensus” section showed a mean consensus of OUTPERFORM with 17 analysts. The same panel reported a last close price of Rs 3,552.95 and an average target price of Rs 4,313.94, implying a spread of +21.42% versus the last close. The highest price target shown was Rs 4,900.00, and the lowest was Rs 3,480.00, translating into spreads of +37.91% and -2.05% versus the last close, respectively. Separately, another line in the material mentioned a max estimate of Rs 4,700.00 and a min estimate of Rs 3,450.00.

Recent brokerage actions cited in the data

The research history table included multiple actions and target revisions. It showed Nomura adjusting CEAT’s price target to INR 4,613 from INR 4,525 while keeping a Buy (22/01). It also showed Asian Markets downgrading CEAT to Sell from Hold with a price target of INR 3,750 (10/24/2025), and JM Financial downgrading to Add from Buy with a price target of INR 4,050 (Oct. 20). Another entry showed ICICI Securities upgrading CEAT to Buy from Hold with a price target of INR 4,700 (Oct. 10). These figures illustrate how targets and ratings have shifted alongside price moves.

Key numbers at a glance

Why valuation is central to the call

Nuvama’s downgrade is anchored in the trade-off between operations and valuation. Even with strong March-quarter operational performance, the brokerage’s view is that the current market pricing leaves limited headroom. Its cited forward P/E multiples provide a reference point for how much investors are paying for expected earnings across FY26E to FY28E. The target price framework at 16x FY28E EPS signals what Nuvama considers a fair multiple for CEAT over its forecast horizon.

What investors may track next

Near-term attention is likely to remain on incremental brokerage revisions and how CEAT trades relative to the stated target levels. Investors tracking the stock may also compare Nuvama’s Rs 3,900 target with the consensus average target of Rs 4,313.94, as both are presented in the available data. Further research notes, quarterly results commentary, or additional changes in analyst recommendations could influence sentiment. For now, Nuvama’s downgrade frames the debate around valuation comfort versus operational execution.